A CBT-based Mobile Intervention as First Line Treatment for Adolescent Depression During COVID-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04524598

Recruitment Status : Active, not recruiting

First Posted : August 24, 2020

Last Update Posted : August 16, 2021

Sponsor:

Information provided by (Responsible Party):

Limbix Health, Inc.

Results Submitted - Quality Control (QC) Review Has Not Concluded

Results information for an applicable clinical trial (ACT) is posted within 30 days of submission even if the submission has not completed the ClinicalTrials.gov Results Quality Control (QC) review process. Results information is submitted to ClinicalTrials.gov by the sponsor or investigator, and National Library of Medicine (NLM) staff assess for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.

All versions of ACT results information submissions that have not completed the QC review process are posted on ClinicalTrials.gov (since January 2020). After the QC review process is completed, the results information is posted without QC review comments and previous versions are archived.

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	September 1, 2021
Estimated Study Completion Date :	September 30, 2021

Submission Cycle	Results Submitted to ClinicalTrials.gov	Results Returned after Quality Control Review
1	September 30, 2021	October 8, 2021 Submission with QC Comments
2	November 17, 2021	November 24, 2021 Submission with QC Comments

To Top